Importantly, while BRCA1-mutated, BRCA2-mutated, and WT triple-negative tumors showed high rates of pCR, the frequency of NACT failure (i.e., RCB III) was similar between HR+ BRCA2-associated and WT cancers. The gene discussed is BRCA1; the disease is cancer.